Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
33.05
-0.07 (-0.21%)
Apr 29, 2026, 1:30 PM EDT - Market open
Nanobiotix Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,609 | 1,108 | 148 | 346 | 135 | 289 | |
| Market Cap Growth | 894.39% | 646.34% | -57.08% | 156.46% | -53.41% | -50.20% | |
| Enterprise Value | 1,659 | 1,134 | 131 | 382 | 116 | 231 | |
| Last Close Price | 33.12 | 23.12 | 2.87 | 7.28 | 3.67 | 8.10 | |
| PS Ratio | 42.05 | 28.95 | -19.93 | 8.64 | 26.42 | 96.13 | |
| PB Ratio | - | -11.17 | -2.18 | -169.73 | -4.66 | 9.50 | |
| P/TBV Ratio | - | - | - | - | - | 9.50 | |
| EV/Sales Ratio | 43.36 | 29.63 | - | 9.53 | 22.66 | 76.63 | |
| Debt / Equity Ratio | -1.13 | -1.13 | -0.77 | -27.44 | -1.97 | 1.72 | |
| Net Debt / Equity Ratio | -0.50 | -0.50 | -0.02 | 13.41 | -0.44 | -1.41 | |
| Net Debt / EBITDA Ratio | -4.06 | -4.06 | -0.02 | 1.09 | -0.27 | 0.83 | |
| Net Debt / FCF Ratio | -1.25 | -1.25 | -0.06 | 1.93 | -0.32 | 1.26 | |
| Asset Turnover | 0.48 | 0.48 | - | 0.47 | 0.06 | 0.02 | |
| Quick Ratio | 1.05 | 1.05 | 0.99 | 1.68 | 1.23 | 2.38 | |
| Current Ratio | 1.09 | 1.09 | 1.04 | 1.75 | 1.38 | 2.53 | |
| Return on Equity (ROE) | - | - | - | - | - | -96.66% | |
| Return on Assets (ROA) | -10.06% | -10.06% | -52.89% | -19.72% | -35.38% | -25.00% | |
| Return on Capital Employed (ROCE) | -106.10% | -106.10% | -804.70% | -55.10% | -209.40% | -72.60% | |
| Earnings Yield | -1.75% | -2.54% | -47.53% | -12.69% | -45.21% | -18.47% | |
| FCF Yield | -2.47% | -3.60% | -14.23% | -4.09% | -29.48% | -11.83% | |
| Buyback Yield / Dilution | -1.17% | -1.17% | -27.99% | -5.96% | -0.34% | -42.43% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.